M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Memorial Sloan Kettering Cancer Center, New York

Montefiore-Einstein Center for Cancer Care, The Bronx

Montefiore Medical Center, The Bronx

Penn State Hershey Cancer Center, Hershey

University of Maryland- St Joseph's Medical Center, Towson

Cancer Center of the Carolinas/ITOR, Greenville

Southeastern Regional Medical Center, Newnan

Florida Hospital Tampa, Tampa

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

Clearview Cancer Institute, Huntsville

Ohio State University, Columbus

St. Joseph Mercy Hospital, Ann Arbor

Karmanos Cancer Center, Detroit

University of Wisconsin Hospital and Clinics, Madison

Metro-Minnesota Community Clinical Oncology Program, Saint Louis Park

Mayo Clinic, Rochester

Illinois Cancer Specialists, Arlington Heights

Loyola University Medical Center, Maywood

University of Kansas Cancer Center, Kansas City

Crescent City Research Consortium, Marrero

Ochsner Medical Center, New Orleans

Texas Oncology, P.A., Tyler

Texas Oncology, Tyler

University of Texas Health Sciences Center, San Antonio

University of Colorado School of Medicine - Division of Medical Oncology, Aurora

Poudre Valley Health System, Fort Collins

Arizona Clinical Research Center, Tucson

University of Arizona, Tucson

University of New Mexico Cancer Center, Albuquerque

Northwest Cancer Specialists, Portland

Hartford Healthcare Cancer Institute at Midstate Medical Center, Meriden

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Umass Memorial Medical Center, Worcester

The Ottawa Hospital Cancer Center, Ottawa

Sunnybrook Health Sciences Centre, Toronto

CHUM Hospital St-Luc, Montreal